Vertex Pharmaceuticals
Price & Volume
Stats
See moreOpen | $512.44 |
Previous Close | $510.08 |
Day Range | $506.47-$514.53 |
52W Range | $402.58-$560.25 |
Market Cap | $129.2B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $12.5B |
Revenue Growth (YoY) | 12.5% |
Gross Profit (12 Mos) | $6.9B |
Diluted EPS | $17.17 |
News
See moreYahoo Finance • 5 days ago
NVIDIA And 2 Elite Undervalued Stocks To Own
Yahoo Finance • 10 days ago
Vertex (VRTX) or Regeneron (REGN)? Two Biotech Moats, Two Very Different Bets
Yahoo Finance • 11 days ago
Vertex Pharmaceuticals And 2 Other Top Gene Therapy Stocks
Yahoo Finance • 14 days ago
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,400 |